1. Search Result
Search Result
Results for "

Labetuzumab govitecan

" in MCE Product Catalog:


Inhibitors & Agonists


Inhibitory Antibodies

Cat. No. Product Name Target Research Areas
  • HY-P99681
    Labetuzumab govitecan

    IMMU 130; hMN-14-SN-38

    Antibody-Drug Conjugates (ADCs) Cancer
    Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer.
  • HY-128945

    ADC Linker Cancer Inflammation/Immunology
    CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker.